FDA Inspection
Lupin LimitedLupin Limited – FDA Inspection, Feb 8, 2019
Record Details
This FDA Inspection record concerns Lupin Limited, with an inspection on February 8, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dc3721e8-c7f2-43b4-b548-6fdf0d276bba
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1078793
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lupin Limited
10| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| September 18, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2017 | Not classified | Office of Inspections and Investigations | |
| April 7, 2017 | Not classified | Office of Inspections and Investigations | |
| March 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lupin Limited
- FDA Inspection 1290876 - 2025-11-21
- FDA Inspection 1152219 - 2021-09-18
- FDA Inspection 1025679 - 2017-07-21
- FDA Inspection 1013797 - 2017-04-07
- FDA Inspection 965791 - 2016-03-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.